Fortis Life Sciences

ONE FORCE
FOWARD

Vertically integrated capabilities for
complex life science workflows

Our Story

We are Fortis Life Sciences.
Where Science Finds Momentum.

Fortis was established in 2020 to create a more unified and scalable approach to supporting modern research and development.

Together, Fortis provides capabilities across antibodies, diagnostic components, molecular biology reagents, engineered nanoparticles, and viral vector platforms so you can work with greater continuity across complex scientific workflows.

As a result, work that once required multiple suppliers can move forward with stronger technical alignment, a more stable supply chain, and a partner better equipped to support discovery, translational research, and advanced biologics development.

OCTOBER 2020
Bethyl Labs
For more than 50 years, Bethyl Laboratories has delivered premium-quality antibodies, proteins, and kits manufactured in-house in Montgomery, Texas. Reagents undergo rigorous validation across immunoassays including flow cytometry, spatial biology, and ELISA.
Founded in 1972
JUNE 2021
nanoComposix
nanoComposix expanded Fortis capabilities in nanomaterial development and production. Highly characterized particles support therapeutics, diagnostics, and applied technologies worldwide.
Founded in 2004
JUNE 2021
Empirical Bioscience
Empirical Bioscience added genomic technologies and expanded recombinant protein manufacturing. The portfolio includes enzymes, buffers, master mixes, and molecular biology reagents supporting diagnostic and genomics programs.
Founded in 2010
JUNE 2021
Arista Biologicals
Arista Biologicals strengthened point-of-care and lateral flow diagnostics with highly characterized capture and detector antibodies, antigens, and controls. Integrated assay development and conjugation services reduce supplier risk and shorten development timelines.
Founded in 1993
JUNE 2021
Abcore
Abcore became a center of excellence for VHH discovery, offering phage display services and AbNano VHH libraries to address difficult and emerging targets across research, therapeutic, and diagnostic programs.
Founded in 2011
JUNE 2021
IPOC
International Point of Care expanded Fortis lyophilization capabilities for molecular and immunodiagnostic testing. Freeze-dried reagents improve stability, reproducibility, and shelf life for global diagnostic programs.
Founded in 2008
JUNE 2021
Vector Biolabs
Vector Biolabs strengthened viral vector design and production, offering catalog and end-to-end AAV and adenoviral solutions that accelerate discovery and translational programs.
Founded in 2004

Proven Scientific Legacies

6
North American manufacturing and R&D locations with three operating under ISO 13485 certification and cGMP standards
1,000+
Biopharma, diagnostics, research, and applied technology customers globally
30,000+
Citations in peer-reviewed scientific publications
75+
Distributors serving customers across 65 countries

Harness the Power of Many

Premium Portfolio

Advance research and clinical success with products developed and validated in-house, backed by rigorous quality controls.

Custom Solutions

We design and manufacture reagents and components customized to our customers exact specifications for optimized performance and results.

High Impact Expertise

Hundreds of biologists, chemists, and manufacturing experts working hand in hand with our customers to develop and scale life-changing breakthroughs

Our Leadership Team

Fortis Life Sciences is guided by a leadership team defined by deep industry expertise, strategic insight, and a steadfast commitment to innovation. With extensive domain expertise across antibodies, diagnostics, genomics, nanomaterials, and viral vectors, our leaders bring a proven record of strengthening respected brands and driving growth. Together, they guide the company forward with clarity, purpose, and a bold focus on sustainable progress that supports customer discoveries that shape medicine, diagnostics, and applied science.

Board of Directors

Our Board of Directors provides strategic oversight and the guidance to ensure Fortis Life Sciences remains disciplined, growth-oriented, and aligned with long-term scientific and commercial objectives.

Darren M. Black

Darren joined Summit Partners in 2013 and focuses on healthcare and life sciences investments. He currently serves on multiple healthcare boards including LifeStance Health (NASDAQ: LFST), Sound Physicians, U.S. Renal Care, VaxCare, and others.

Prior to Summit, Darren was a Managing Partner at SV Life Sciences and previously co-founded and led two healthcare companies. He began his career in healthcare consulting at Accenture.

Darren holds an A.B. from Harvard College and an MBA from the Wharton School of the University of Pennsylvania.

Julie Coletti is EVP, Chief Legal & Regulatory Officer at Align Technology (NASDAQ: ALGN), a global medical device company and leader in digital dentistry. She advises the Board and Executive Committee and leads legal, regulatory, and quality organizations worldwide.

Prior to Align, Julie served as Vice President and Global General Counsel for Danaher's Dental Platform (NYSE: DHR) and held senior leadership roles at Bayer HealthCare.

Heiner brings more than 35 years of experience in molecular diagnostics and life sciences leadership. A pioneer in the early commercialization of PCR technology, he held multiple global leadership roles at Roche Diagnostics, including President and CEO of Roche Molecular Systems.

Heiner has served on numerous public and private boards across the U.S., Europe, and Israel and is widely recognized for advancing molecular diagnostic platforms globally.

Ross joined Summit Partners in 2009 and focuses on healthcare and life sciences investments. His board experience spans healthcare services, practice management, diagnostics, and specialty pharmaceutical platforms.

Previously, Ross worked at the Center for Medicare and Medicaid Innovation and in healthcare investment banking at Cowen & Company.

Ross holds a B.A. from Bowdoin College and an MBA from the Wharton School of the University of Pennsylvania.

1 / 4

Our Promise...

To deliver the caliber of reagents and tools that elevate every experiment.

To empower the bold minds pushing the frontiers of discovery.

To be the backbone behind breakthroughs that move humanity forward.

Talk To An Expert